Webinars

New Activities

Antifungal resistance in Candida and ...

Fungal infections, in their various manifestations, affect millions of people worldwide and cause a very high morbidity and mortality.The ...

Register
New antibiotic summary cards

The Alliance for the Prudent Use of Antibiotics (APUA) is proud to announce the launch of the third batch of &...

View / download
One health aspects of AMR and ...

The on-demand recording of the recent webinar from Asia Pacific Society of Clinical Microbiology & Infection and the International ...

Watch webinar
Resources for preparing and using ...

This free E-module is designed to help you increase your understanding about how and why antibiograms are used in hospital ...

Read more

One health aspects of AMR and infections in Asia

9 May @ 11.00 (CET) / 17.00 (China / Singapore)


1. One Health and AMR – (Xiao YongHong, Zhejiang University)
2. Severe fever with thrombocytopenia syndrome (SFTS) - (Dong-Min Kim, Chosun University)
3. Nipah virus - (Linfa Wang, Duke Global Health)

Description
Asia Pacific Society of Clinical Microbiology and Infection (APSCMI) is a federation of infectious disease, microbiology and infection control societies in the Asia Pacific and a close partner of International Society of Antimicrobial Chemotherapy (ISAC).

The COVID-19 pandemic is a stark reminder of the importance of One Health approach to combat major challenges in infectious diseases. For this webinar we have focused on One Health and emerging infections from the Asia Pacific.

Antimicrobial resistance is a slow-burn pandemic that cannot be solved without multisectoral One Health approach. Nipah virus and severe fever with thrombocytopenia syndrome (SFTS) caused by tick-borne Bandavirus are emerging viral infections of significant mortality in South and East Asia respectively.

This webinar brings experts from the Asia Pacific to share on these three areas to stimulate dialogue and collaboration in our international infectious disease community.

Speakers

Professor Yonghong Xiao is a PI, Vice-director, State Key Laboratory of Diagnosis & Treatment of Infectious Diseases at the 1st Affiliated Hospital, School of Medicine, Zhejiang University.

His major interests include infectious diseases, basic and clinical research in antimicrobial agents, bacterial resistant surveillance and mechanisms, clinical pharmacology and antimicrobial stewardship.

He is the founder & leader of MOH national antibacterial resistant investigation net. He conducted the first One-Health AMR containment programme in China in 2015. He holds many positions in societies and associations both domestic and international. He has published more than 500 peer-review papers and 30 books and chapters.

Dr Dong-Min Kim is a professor in the Division of Infectious Diseases at Chosun University Hospital and Chosun University College of Medicine. His research interests include vector-borne infectious diseases such as scrub typhus, rickettiosis, severe fever thrombocytopenia syndromes, Lyme disease, etc., as well as neglected infectious diseases including Japanese encephalitis virus, dengue virus, malaria, and parasitic infections. He is currently conducting research on the development of diagnostic methods for infectious diseases, therapeutic agents, and vaccines.

Professor Linfa Wang is a professor of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, and the inaugural executive director of PREPARE, Ministry of Health, Singapore. He is an international leader in the field of emerging zoonotic viruses and virus-host interaction and in identification of bats as an important reservoir for emerging viruses. Prof Wang was elected to the Australian Academy of Technological Sciences and Engineering in 2010, the American Academy of Microbiology in 2021 and the Australian Academy of Sciences in 2023. He received the Singapore President Science Award in 2021.

Professor David Lye is Director of Infectious Disease Research and Training Office at National Centre for Infectious Disease (NCID), professor at Lee Kong Chian School of Medicine and Yong Loo Lin School of Medicine, and deputy executive director, Programme for Research in Epidemic Preparedness and Response (PREPARE), Singapore. He is senior consultant, Department of Infectious Diseases, TTSH. At TTSH, he founded and led the Antimicrobial Stewardship Programme from 2009 to 2018. At NCID, he headed Singapore Infectious Disease Clinical Research Network (SCRN) from 2014 to 2020, and Training and Education Office from 2018 to 2020. He has been the chair of the National Antimicrobial Stewardship Expert Panel since 2014. He is a member of National Antimicrobial Resistance Control Committee, One Health Antimicrobial Resistance Project Team and Expert Committee on COVID-19 Vaccination, Ministry of Health, Singapore.

Prof. David Lye is President of the Asia Society of Clinical Microbiology & Infection (APSCMI).

Dr David Jenkins is a consultant medical microbiologist at University Hospitals of Leicester NHS Trust, where he has been the infection prevention lead doctor for the last 25 years as well as antimicrobial stewardship lead. He is also an honorary associate professor at Leicester University and, between 2021-2024, the president of the British Society for Antimicrobial Chemotherapy. His interests include behavioural aspects of antimicrobial prescribing and stewardship as well as data analysis and policy development.

Dr Jenkins is a member of the ISAC Executive Committee.